Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | RXST RxSight, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $4.77 +2.1% | $15.35 +3.1% |
| StockIQ Score | 34F Weak Risk: High | 38F Weak Risk: High |
| Technical | 6F | 24F |
| Fundamental | 30F | 35F |
| Growth | 37F | 50C- |
| Fair Value | 43D | 38F |
| News | 62C+ | 50C- |
| Quality | 58C | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
RxSight (RXST) outperforms Ascentage Pharma (AAPG) in technical (58 vs. 18) and investor scores (46 vs. 37), showing stronger market trends and investor confidence. However, AAPG leads in growth (50 vs. 37), indicating faster expansion potential. Both have similar valuation scores, but AAPG’s weaker overall rating suggests higher risk.
